Literature DB >> 27757576

Immunohistochemical detection of intrathrombotic fibrocytes and its application to thrombus age estimation in murine deep vein thrombosis model.

Mizuho Nosaka1, Yuko Ishida1, Akihiko Kimura1, Takashi Kawaguchi1, Hiroki Yamamoto1, Yumi Kuninaka1, Toshikazu Kondo2.   

Abstract

Deep vein thrombi are dissolved after fibrosis process along with an increase of thrombus age. Fibrocytes are circulating bone marrow-derived cells with mesenchymal features that potentially have a unique and critical function in fibrosis. In this study, a double-color immunofluorescence analysis was carried out by using anti-CD45 and anti-collagen type I antibodies to examine the time-dependent appearance of fibrocytes in the murine model of stasis-induced deep vein thrombosis. The thrombus ages were 1, 3, 5, 7, 10, 14, and 21 days. In a thrombus age of less than 5 days, CD45+ and collagen type I+ fibrocytes were never detected. The intrathrombotic fibrocytes were initially observed in thrombi aged 7 days, and their number increased with advances in thrombus age. In a quantitative morphometrical analysis, the average number of intrathrombotic fibrocytes was highest in 14-day-old thrombi, and all of the five samples aged 14 days had the fibrocyte number of more than 25, and in three out of them, the number of intrathrombotic fibrocytes was over 30. On the contrary, in all of thrombus samples with the postligation intervals of 10 and 21 days, the number of intrathrombotic fibrocytes was less than 25. These observations imply that thrombi containing fibrocytes are at least 7 days old and that a fibrocyte number exceeding 30 would indicate the thrombus age of approximately 14 days. Our observations indicate that the detection of fibrocytes could be useful for thrombus age determination.

Entities:  

Keywords:  Fibrocyte; Forensic pathology; Immunohistochemistry; Thrombus age determination

Mesh:

Year:  2016        PMID: 27757576     DOI: 10.1007/s00414-016-1465-6

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  34 in total

1.  Glucagon-blood catecholamine test: use in isolated and familial pheochromocytoma.

Authors:  A G Siqueira-Filho; S G Sheps; F T Maher; N S Jiang; L R Elveback
Journal:  Arch Intern Med       Date:  1975-09

2.  Fibrocyte-like cells from intrauterine growth restriction placentas have a reduced ability to stimulate angiogenesis.

Authors:  Meghan R Riddell; Bonnie Winkler-Lowen; Yanyan Jiang; Larry J Guilbert; Sandra T Davidge
Journal:  Am J Pathol       Date:  2013-07-05       Impact factor: 4.307

3.  Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.

Authors:  Mizuho Nosaka; Yuko Ishida; Yumi Kuninaka; Akihiko Kimura; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2012-02-24       Impact factor: 2.686

4.  Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function.

Authors:  Yuko Ishida; Ji-Liang Gao; Philip M Murphy
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

5.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 6.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

7.  Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.

Authors:  Matthias Schmidt; Guo Sun; Martin A Stacey; Luca Mori; Sabrina Mattoli
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

Review 8.  Fibrocytes in lung disease.

Authors:  Brigitte N Gomperts; Robert M Strieter
Journal:  J Leukoc Biol       Date:  2007-06-05       Impact factor: 4.962

9.  Fibrocytes are not an essential source of type I collagen during lung fibrosis.

Authors:  Kathryn R Kleaveland; Miranda Velikoff; Jibing Yang; Manisha Agarwal; Richard A Rippe; Bethany B Moore; Kevin K Kim
Journal:  J Immunol       Date:  2014-10-03       Impact factor: 5.422

10.  Circulating fibrocytes stabilize blood vessels during angiogenesis in a paracrine manner.

Authors:  Jinqing Li; Hong Tan; Xiaolin Wang; Yuejun Li; Lisa Samuelson; Xueyong Li; Caibin Cui; David A Gerber
Journal:  Am J Pathol       Date:  2013-12-02       Impact factor: 4.307

View more
  4 in total

1.  Histological criteria for age determination of fatal venous thromboembolism.

Authors:  Valeria Maffeis; Lorenzo Nicolè; Claudio Rago; Ambrogio Fassina
Journal:  Int J Legal Med       Date:  2017-10-19       Impact factor: 2.686

2.  Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization.

Authors:  Jiacheng Sun; Zhiwei Zhang; Teng Ma; Ziying Yang; Jinlong Zhang; Xuan Liu; Da Lu; Zhenya Shen; Junjie Yang; Qingyou Meng
Journal:  Stem Cell Res Ther       Date:  2018-08-23       Impact factor: 6.832

3.  The application of autophagy to thrombus age estimation in murine deep vein thrombosis model.

Authors:  Mizuho Nosaka; Yuko Ishida; Yumi Kuninaka; Akira Taruya; Akihiko Kimura; Emi Shimada; Hiroki Yamamoto; Tomomi Michiue; Fukumi Furukawa; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2019-11-12       Impact factor: 2.686

Review 4.  State-of-Art in the Age Determination of Venous Thromboembolism: A Systematic Review.

Authors:  Nicola Di Fazio; Giuseppe Delogu; Costantino Ciallella; Martina Padovano; Federica Spadazzi; Paola Frati; Vittorio Fineschi
Journal:  Diagnostics (Basel)       Date:  2021-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.